Patent details
EP3478719
Title:
USE OF ANTI-SCLEROSTIN ANTIBODIES IN THE TREATMENT OF OSTEOGENESIS IMPERFECTA
Basic Information
- Publication number:
- EP3478719
- PCT Application Number:
- GB2017053850
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP178231908
- PCT Publication Number:
- WO2018115880
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- USE OF ANTI-SCLEROSTIN ANTIBODIES IN THE TREATMENT OF OSTEOGENESIS IMPERFECTA
- French Title of Invention:
- UTILISATION D'ANTICORPS ANTI-SCLÉROSTINE DANS LE TRAITEMENT DE L'OSTÉOGENÈSE IMPARFAITE
- German Title of Invention:
- VERWENDUNG VON ANTI-SCLEROSTIN-ANTIKÖRPERN BEI DER BEHANDLUNG VON OSTEOGENESIS IMPERFECTA
- SPC Number:
-
Dates
- Filing date:
- 21/12/2017
- Grant date:
- 20/01/2021
- EP Publication Date:
- 08/05/2019
- PCT Publication Date:
- 28/06/2018
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 20/01/2021
- EP B1 Publication Date:
- 20/01/2021
- EP B2 Publication Date:
- EP B3 Publication Date:
- 18/12/2024
- Lapsed date:
- Expiration date:
- 21/12/2037
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 11/12/2024
-
-
- Name:
- Mereo Biopharma 3 Limited
- Address:
- 4th Floor 1 Cavendish Place, London W1G 0QF, United Kingdom (GB)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 21/01/2021
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
1
- Name:
- RIGGS, Matthew Manning
- Address:
- United States (US)
2
- Name:
- EUDY, Rena Joy
- Address:
- United States (US)
3
- Name:
- JUNKER, Uwe
- Address:
- Switzerland (CH)
4
- Name:
- HALL, Anthony Kent
- Address:
- Netherlands (NL)
5
- Name:
- KNEISSEL, Michaela
- Address:
- Switzerland (CH)
Priority
- Priority Number:
- 201662437353 P
- Priority Date:
- 21/12/2016
- Priority Country:
- United States (US)
Classification
- IPC classification:
-
C07K 16/22;
A61K 39/395;
A61P 19/08;
A61K 39/00;
Publication
European Patent Bulletin
1
- Issue number:
- 202103
- Publication date:
- 20/01/2021
- Description:
- Grant (B1)
2
- Issue number:
- 202425
- Publication date:
- 19/06/2024
- Description:
- Request for limitation Filed (Art.105a)
3
- Issue number:
- 202448
- Publication date:
- 27/11/2024
- Description:
- Request for limitation of patent allowed
4
- Issue number:
- 202451
- Publication date:
- 18/12/2024
- Description:
- Limited Patent Specification (B3)
5
- Issue number:
- 202108
- Publication date:
- 24/02/2021
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
Annual Fees
- Annual Fee Due Date:
- 31/12/2025
- Annual Fee Number:
- 9
- Annual Fee Amount:
- 115 Euro
- Expected Payer:
-
- Last Annual Fee Payment Date:
- 13/12/2024
- Last Annual Fee Paid Number:
- 8
- Last Annual Fee Paid Amount:
- 99 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM